Granahan Investment Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-199,541
Closed -$3.2M 187
2021
Q4
$3.2M Sell
199,541
-31,517
-14% -$593K 0.07% 171
2021
Q3
$4.84M Sell
231,058
-28,384
-11% -$684K 0.09% 151
2021
Q2
$6.97M Buy
259,442
+14,165
+6% +$415K 0.13% 140
2021
Q1
$7.81M Sell
245,277
-44,584
-15% -$1.08M 0.17% 110
2020
Q4
$6.63M Buy
289,861
+105,986
+58% +$2.44M 0.15% 113
2020
Q3
$4.63M Sell
183,875
-35,231
-16% -$962K 0.16% 112
2020
Q2
$6.12M Sell
219,106
-5,532
-2% -$96.1K 0.22% 99
2020
Q1
$1.31M Sell
224,638
-1,313
-0.6% -$11.9K 0.07% 155
2019
Q4
$2.46M Buy
225,951
+1,695
+0.8% +$16.8K 0.11% 131
2019
Q3
$2.86M Buy
224,256
+9,841
+5% +$142K 0.16% 120
2019
Q2
$3.64M Sell
214,415
-13,304
-6% -$229K 0.18% 108
2019
Q1
$4.09M Sell
227,719
-12,769
-5% -$221K 0.22% 109
2018
Q4
$3.05M Sell
240,488
-6,428
-3% -$108K 0.22% 109
2018
Q3
$5.29M Buy
246,916
+6,925
+3% +$148K 0.29% 95
2018
Q2
$4.96M Buy
239,991
+20,727
+9% +$467K 0.3% 105
2018
Q1
$5.52M Buy
219,264
+43,866
+25% +$1.07M 0.4% 86
2017
Q4
$3.33M Buy
+175,398
New +$3.27M 0.26% 114

Other funds holding MGNX

Granahan Investment Management's MGNX Position: Q1 2022 in Review

Granahan Investment Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 199,541 shares — an estimated $3.2M sold.

Granahan Investment Management first reported a position in MGNX in Q4 2017 and held it in 17 quarters. The position peaked at $7.81M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Granahan Investment Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Granahan Investment Management sold 199,541 MacroGenics shares in Q1 2022, an estimated $3.2M.
  • Granahan Investment Management first reported a position in MacroGenics in Q4 2017 and held it in 17 quarters.
  • Granahan Investment Management's MacroGenics position peaked at $7.81M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.